All Articles

For decades, the delivery room has relied on ambiguous tech, fueling anxiety and unnecessary surgeries. Now, a new wearable system aims to finally provide clarity.

As Starlight Investments tops off a new rental project, its infill strategy offers a glimpse into how Toronto might build its way out of a housing crisis.

Deloitte's new AI agent network isn't just automation. It's a strategic move to redefine the audit, placing immense pressure on both rivals and regulators.

Blackbird Health's expansion into Bala Cynwyd is more than a new clinic; it's a strategic move into a pediatric mental healthcare market at its breaking point.

A snack brand's four-month surge into 350 Target stores is more than a success story; it's a blueprint for the future of food, retail, and mission.

Following a $30M funding round, Mammogen appoints Dr. Elise Berman as CMO to spearhead its genTRU-breast™ test, aiming to solve the dense breast dilemma.

After 25 years, the premier industrial cybersecurity conference is moving to Nashville, a sign of the city's tech rise and the evolving fight for our critical infrastructure.

Roundhill doubles down on the AI memory boom with a leveraged ETF. We explore the strategy behind the new RAM fund, its link to the blockbuster DRAM ETF, and the critical risks.

BackBox's top G2 rankings reveal a deeper trend: in the high-stakes world of network automation, the most effective tools are the ones teams actually use.

With new leadership and backing from AI giant Rezolve, Subsquid is pivoting its onchain data engine to the enterprise. Is this the moment Web3 tech grows up?

In a strategic move underscoring its American ambitions, UK-based retail powerhouse JD Sports Fashion plc has upgraded its U.S. trading to the OTCQX Best Market, signaling a new chapter in its bid for North American market dominance.

With a new patent for its AI-powered VVC device, Zero Candida is betting on smart technology to solve a persistent health issue where drugs often fail.

Plug Power's new Danish electrolyzer is more than a project; it's a test of its 'disciplined growth' strategy and a model for Europe's energy future.

Vault's 2026 rankings are out, and the message is clear: Elite boutique banks like Centerview Partners are rewriting the rules for success, prioritizing culture and compensation over pure prestige.

An alliance of biopharma innovators is set to discuss a critical hurdle in medicine: delivering RNA therapies to tissues beyond the liver, a key to unlocking new treatments.

With M&A veterans Martin Babler and Troy Cox joining its board, MapLight Therapeutics is signaling a strategic shift from foundational research to late-stage execution.

A Texas contractor’s advice on renovation timelines reveals a deeper story: a new media model blending education and advertising to de-risk projects and redefine local commerce.

A new AI tool is scoring thousands of scientific papers, promising to find top research faster and more fairly. But can it truly replace human judgment?

As new EPA rules create a compliance crisis for cities, Calgon Carbon is commercializing a cheaper, greener, custom solution to clean 'forever chemicals'.

PetVivo's acquisition of PiezoBioMembrane signals a bold leap from animal care to human health, leveraging advanced biomaterials to chase a larger market.